Inland Empire Health Plan releases year one results from Health Homes Program
In June, Inland Empire Health Plan (IEHP) released the year one results for its Health Homes Program (HHP). The HHP, which provides integrated care management for the plan’s most vulnerable members, saw improvements in both utilization and outcomes during its first year.
IEHP’s program launched on January 1, 2019, for members with chronic physical conditions and substance use disorders, and then expanded in July of that year for members with severe mental illness. In its first year, a network of 50 Community-Based Care Management Entities were established to provide integrated care to those in the HHP model.
January saw 2,018 enrolled health home members; that number grew to 6,779 members in October. However, this is a small portion of the number of HHP-eligible members, according to the report.
In an analysis of member acuity level, IEHP found that 2.8% of HHP-enrolled members were chronically homeless, 57% had 3 or more ED visits, 56% had one or more inpatient visits, and 70% had 3 or more HHP conditions (members can be categorized into more than one category). The top conditions present for enrollees were high blood pressure, diabetes, and major depressive disorder.
In the first year of the program, HHP enrolled members had a statistically significant higher rate of primary care provider visits and a lower rate of emergency department visits compared to the control group. Though not statistically significant, HHP members saw, on average, fewer inpatient admissions, fewer bed days, and fewer urgent care visits.
HHP members also had a statistically significant higher mean cost compared to the control group.
“Although initial total cost of care analysis revealed a statistically significant increase in overall cost for HHP-enrolled Members, it is too early in the life of the program to draw any conclusions about the HHP’s overall impact on total cost of care,” reads the report.
Year one results also show statistically significant improvements in clinical outcomes for Systolic Blood Pressure, HbA1C, and the Patient Health Questionnaire-9 (a depression assessment).